Chemically more stable than ghrelin
However, the consistency, magnitude, and biological plausibility of the ASCO GI 2026 signal strongly justify future randomized prevention trials
Exenatide is a shorter-acting GLP-1 receptor agonist with lower affinity and reduced half-life compared to liraglutide, which may partly explain its neutral effect on testosterone levels [17]
The medication reduces appetite and slows gastric emptying, making you feel full faster and stay full longer
We also talk strategy, maintenance dosing, combination GLP-1 + amylin approaches, pricing pressures, cash-pay access, and what this all means for patients navigating a rapidly changing obesity treatment landscape